Apeloa CDMO is the contract manufacturing focused business of Apleoa Pharmaceutical Co. Ltd., part of the Hengdian Group. Founded in 1989, Apeloa has strategically developed the business towards a goal of becoming one of the leading pharmaceutical companies in the world. Part of that strategy for success included becoming one of the leading contract services organizations, supporting the world’s pharmaceutical and biotechnology companies, with world class discovery, development, and manufacturing services for Active Pharmaceutical Ingredients (APIs), Intermediates and Registered Starting Materials (RSMs). The growth and success of Apeloa CDMO was a result of the company’s commitment to providing leading edge science combined with best-in-class customer service. Apeloa’s CDMO business is an important part of the parent company’s overall strategic plans and fit into their 30+ year history of growth through technical excellence.
